Bayer Commits $5.6 Billion to Glyphosate Alternatives Amid 13,000 Lawsuits Over the Weedkiller

Bayer AG will pump about 5 billion euros ($5.6 billion) of its research and development budget into alternatives to its weedkiller glyphosate over the next decade as it battles more than 13,000 lawsuits claiming the herbicide causes cancer. Trying to ease concerns about the controversial compound, the German chemical and drug company said it will […]

The U.S. EPA Just Gave Bayer a Gift in Its Battle Against Weed Killer Cancer Claims

The embattled management at Bayer just got a handy boost from the U.S. Environmental Protection Agency (EPA)–a draft report that says glyphosate, the active ingredient in its Roundup weedkiller, does not cause cancer. This is no change of stance on the EPA’s part, but the timing of the new report should prove beneficial to Bayer, […]

Bayer CEO Has 9 Months to Overcome Shareholders’ Extraordinary Rebuke of His Monsanto Deal

Bayer Chief Executive Werner Baumann has nine months to prove he shouldn’t be kicked out as a result of last year’s Monsanto acquisition, a corporate law expert warned Tuesday. Professor Christoph Schalast, a mergers and acquisition specialist at the Frankfurt School of Finance and Management, said Friday’s unprecedented rebuke of Bayer’s management was in part […]

Bayer’s Management Face A No-Confidence Vote Over Monsanto Deal. Here’s What You Need to Know.

The Monsanto glyphosate drama may be about to hit the agriculture firm’s new owners where it hurts. Bayer’s management faces a vote of no confidence at the German company’s annual general meeting, which is taking place Friday. Amid widespread concerns over the wisdom of Bayer’s Monsanto takeover last year, the vote looks set to be […]

Bayer Gets Temporary Relief from Its Monsanto-Roundup Woes

Bayer AG’s earnings report gave Chief Executive Officer Werner Baumann a welcome boost as he prepares for a key meeting Friday where some investors will vent concerns about the troubled Monsanto acquisition. The agriculture unit posted a 5.5% jump in first-quarter sales after adjusting for currency and portfolio changes, the company said as it reported […]

Bayer CEO Faces a Shareholder Reckoning Over the Monsanto Deal

Bayer AG is facing mounting opposition ahead of what’s shaping up to be its most contentious annual meeting in years, with influential shareholders faulting management for failing to foresee the risks of the company’s biggest deal ever. A growing number of shareholders have said they won’t support executives and supervisory board members in a no-confidence […]

Xeralto to Become First Prescription Drug With TV Ads That Includes Pricing

Xeralto has been a popular drug-thinner for years–and the target of more than 25,000 lawsuits recently settled by Bayer AG and Johnson & Johnson for $775 million. Now Xeralto, a brand name for generic rivaroxaban, is getting some attention for something different. It’s about to become the first drug to include prices in television ads, […]

Jury Orders Bayer to Pay $81 Million in Second Trial Claiming Roundup Weedkiller Caused Cancer

A jury awarded $81 million in damages to a man who claimed that Roundup, a weedkiller sold by Bayer AG, caused his non-Hodgkins lymphoma, Reuters said Wednesday. The six-person jury in the U.S. District Court in San Francisco ordered Bayer to pay Edwin Hardeman $75 million in punitive damages and $5.9 million in compensatory damages, […]

More than 11,000 People Are Now Suing Bayer over Weedkiller Cancer Risk

Bayer is now facing lawsuits from around 11,200 plaintiffs over the health implications of Roundup and Ranger Pro, its glyphosate-based weedkillers. The German life science giant revealed the figure Wednesday as it announced its results for fiscal 2018. Full-year sales were up 13% and EBITDA before special items up 2.8%, but full-year net earnings were […]